Offer - Urjas Oil for just ₹ 1
Glipijub M Forte Tablet PR, a prescription drug, is manufactured in various forms such as Tablet. Glipijub M Forte Tablet PR also has some secondary and off-label uses. These are listed below.
The correct dosage of Glipijub M Forte Tablet PR depends on the patient's age, gender, and medical history. Individual symptoms and route of administration also determines the right dosage. This information has been provided in detail in the dosage section.
The most common side effects of Glipijub M Forte Tablet PR are Stomach Upset, Difficulty urinating, Hypoglycemia (Low blood sugar level). Apart from the aforementioned side effects, Glipijub M Forte Tablet PR can also lead to other problems, which have been listed below. Usually, these side effects of Glipijub M Forte Tablet PR go away soon, and do not persist beyond the duration of the treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Furthermore, you should know that effect of Glipijub M Forte Tablet PR is Moderate for pregnant women and Severe for women who are breastfeeding. In addition, Glipijub M Forte Tablet PR's effects on the liver, heart and kidney are discussed below in the Glipijub M Forte Tablet PR related warnings section.
Glipijub M Forte Tablet PR is not recommended if you suffer from certain medical conditions as it can have adverse effects. Congestive Heart Failure (CHF), Anemia, Shock are examples of such conditions. Other conditions have been mentioned below in the Glipijub M Forte Tablet PR contraindications section.
Additionally, Glipijub M Forte Tablet PR may also adversely react with other medicines. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Glipijub M Forte Tablet PR is considered safe while driving, and is addictive.
Glipijub M Forte Tablet PR is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| 13 - 18 years (Adolescent) |
|
| Adult |
|
| Geriatric |
|
Is the use of Glipijub M Forte Tablet PR safe for pregnant women?
Glipijub M may have some side effects during pregnancy. Pregnant women should discontinue the use of Glipijub M, and talk to their doctor, if they notice any discomfort.
Is the use of Glipijub M Forte Tablet PR safe during breastfeeding?
Taking Glipijub M may lead to serious side effects if you are breastfeeding. Glipijub M should not be taken by breastfeeding women unless prescribed by the doctor.
What is the effect of Glipijub M Forte Tablet PR on the Kidneys?
Information about safety of Glipijub M for kidney is not available since scientific research on this topic is yet to be done.
What is the effect of Glipijub M Forte Tablet PR on the Liver?
In the absence of any scientific study on the side effects of Glipijub M on the liver, information on safety of Glipijub M for liver is unavailable.
What is the effect of Glipijub M Forte Tablet PR on the Heart?
Information about safety of Glipijub M for heart is not available since scientific research on this is yet to be done.
If you are suffering from any of the following diseases, you should not take Glipijub M Forte Tablet PR unless your doctor advises you to do so -
Is this Glipijub M Forte Tablet PR habit forming or addictive?
Glipijub M Forte Tablet PR does not cause addiction.
Interaction between Food and Glipijub M Forte Tablet PR
Due to the absence of research, it is difficult to say how Glipijub M Forte Tablet PR and food will interact.
Interaction between Alcohol and Glipijub M Forte Tablet PR
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Glipijub M Forte Tablet PR.
Yes, you can take Glipijub M with a beta-blocker. People with diabetes tend to develop heart disease or stroke at an earlier age than the general population. One reason for this is that high glucose levels increase your risk of high blood pressure (hypertension). No harmful interactions are seen between them. However, a recent study suggests that beta-blockers can decrease the plasma level of Glipijub M and long-term use can increase lactic acid and uric acid in the blood.
Glipijub M is used with a proper diet and exercise program, to treat diabetes. It is also used with other medication to reduce the high blood sugar. It is used in a patient with type2 diabetes. It is also used in the treatment of polycystic ovarian syndrome (PCOS) and cancer.
Yes, Glipijub M can cause night sweat, the exact mechanism of sweating is not known. But some research suggests that Glipijub M causes hypoglycemia (low blood sugar) especially at night which can cause night sweats. Need to monitor your blood glucose level regularly, and talk to your doctor as your dose of Glipijub M may need to be adjusted.
Glipijub M contain metformin, is an oral antidiabetic drug which belongs to the class of biguanide. It is the first-line medication for the treatment of type 2 diabetes, particularly in people who are overweight. It is also used in the treatment of polycystic ovary syndrome. Moreover, it also reduces the risk of cardiovascular complications of diabetes.
Glipijub M increases the sensitivity of insulin, young women with PCOS often have elevated insulin levels and are more likely to develop diabetes. It is often prescribed for women with PCOS to help prevent diabetes. A lifestyle that includes healthy nutrition and daily exercise is the most important part of a PCOS treatment plan.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826